Contineum Therapeutics, Inc. (CTNM)
9.86
+0.08
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
9.885
+0.02
(+0.25%)
After-Hours: 19:59
Contineum Therapeutics Price : 9.86 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 9.76 | 10.15 | 9.36 | 9.86 | 265894.0 |
| Nov 12, 2026 | 10.71 | 10.89 | 9.74 | 9.78 | 315430.0 |
| Nov 11, 2026 | 10.68 | 10.90 | 10.57 | 10.77 | 287648.0 |
| Nov 10, 2026 | 10.24 | 10.65 | 10.01 | 10.56 | 249721.0 |
| Nov 09, 2026 | 9.74 | 10.50 | 9.32 | 10.30 | 264652.0 |
| Nov 06, 2026 | 8.96 | 9.79 | 8.59 | 9.52 | 343536.0 |
| Nov 05, 2026 | 9.59 | 9.84 | 8.65 | 8.81 | 584009.0 |
| Nov 04, 2026 | 10.00 | 10.32 | 9.56 | 9.79 | 804448.0 |
| Nov 03, 2026 | 9.57 | 9.94 | 9.54 | 9.69 | 525811.0 |
| Nov 02, 2026 | 9.46 | 9.64 | 9.13 | 9.56 | 369009.0 |
| Oct 30, 2026 | 9.14 | 9.58 | 8.93 | 9.39 | 458622.0 |
| Oct 29, 2026 | 9.13 | 9.865 | 9.13 | 9.33 | 566923.0 |
| Oct 28, 2026 | 8.92 | 9.34 | 8.59 | 9.15 | 570480.0 |
| Oct 27, 2026 | 8.18 | 9.12 | 8.02 | 8.99 | 643754.0 |
| Oct 26, 2026 | 8.25 | 8.59 | 8.02 | 8.14 | 402684.0 |
| Oct 23, 2026 | 8.24 | 8.43 | 8.01 | 8.31 | 428770.0 |
| Oct 22, 2026 | 8.32 | 8.750 | 8.12 | 8.395 | 498754.0 |
| Oct 21, 2026 | 8.49 | 8.79 | 8.15 | 8.35 | 1.117M |
| Oct 20, 2026 | 7.38 | 8.70 | 7.145 | 8.46 | 2.201M |
| Oct 19, 2026 | 7.01 | 7.45 | 6.725 | 7.44 | 1.796M |
| Oct 16, 2026 | 7.87 | 7.87 | 6.95 | 7.08 | 1.108M |
| Oct 15, 2026 | 8.25 | 8.56 | 7.72 | 7.90 | 1.021M |
| Oct 14, 2026 | 8.21 | 8.796 | 7.96 | 8.14 | 1.015M |
| Oct 13, 2026 | 8.56 | 8.94 | 8.095 | 8.42 | 2.649M |
| Oct 12, 2026 | 9.90 | 11.54 | 8.425 | 8.565 | 8.468M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.9801 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 6.82 |
| Fulcrum Therapeutics, Inc. | 3.77 |
Price Related Metrics
| Price to Book Value | 1.577 |
| Earnings Yield | -17.95% |
| Market Cap | 387.00M |